322 related articles for article (PubMed ID: 25582996)
21. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits.
Qi M; Hu J; Li J; Li J; Dong W; Feng X; Yu J
Bone; 2012 Jan; 50(1):119-27. PubMed ID: 22023930
[TBL] [Abstract][Full Text] [Related]
22. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
Shiraishi A; Miyabe S; Nakano T; Umakoshi Y; Ito M; Mihara M
BMC Musculoskelet Disord; 2009 Jun; 10():66. PubMed ID: 19527501
[TBL] [Abstract][Full Text] [Related]
23. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
24. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
[TBL] [Abstract][Full Text] [Related]
25. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats.
Brouwers JE; van Rietbergen B; Bouxsein ML
Calcif Tissue Int; 2008 Sep; 83(3):186-91. PubMed ID: 18712432
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP
Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967
[TBL] [Abstract][Full Text] [Related]
27. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
[TBL] [Abstract][Full Text] [Related]
28. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats.
Dikicier E; Karaçaylı Ü; Dikicier S; Günaydın Y
J Craniomaxillofac Surg; 2014 Oct; 42(7):1106-11. PubMed ID: 24530079
[TBL] [Abstract][Full Text] [Related]
29. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
Bonnet N; Beaupied H; Vico L; Dolleans E; Laroche N; Courteix D; Benhamou CL
J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
[TBL] [Abstract][Full Text] [Related]
30. Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association?
Lespessailles E; Jaffré C; Rochefort GY; Dolléans E; Benhamou CL; Courteix D
Lipids; 2010 Apr; 45(4):337-44. PubMed ID: 20229125
[TBL] [Abstract][Full Text] [Related]
31. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
32. Beta-blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats.
Zhang W; Kanehara M; Zhang Y; Wang X; Ishida T
Am J Chin Med; 2007; 35(1):89-101. PubMed ID: 17265554
[TBL] [Abstract][Full Text] [Related]
33. Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats.
Brance ML; Brun LR; Di Loreto VE; Lupo M; Rigalli A
Climacteric; 2014 Aug; 17(4):478-85. PubMed ID: 24205901
[TBL] [Abstract][Full Text] [Related]
34. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
Gamsjaeger S; Buchinger B; Zwettler E; Recker R; Black D; Gasser JA; Eriksen EF; Klaushofer K; Paschalis EP
J Bone Miner Res; 2011 Jan; 26(1):12-8. PubMed ID: 20645415
[TBL] [Abstract][Full Text] [Related]
35. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
36. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
Saag K; Lindsay R; Kriegman A; Beamer E; Zhou W
Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
[TBL] [Abstract][Full Text] [Related]
37. Role of zoledronic acid in the prevention and treatment of osteoporosis.
Räkel A; Boucher A; Ste-Marie LG
Clin Interv Aging; 2011; 6():89-99. PubMed ID: 21594000
[TBL] [Abstract][Full Text] [Related]
38. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
39. Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density.
Bachmann G; Kriegman A; Gonçalves J; Kianifard F; Warren M; Simon JA
Menopause; 2011 Aug; 18(8):851-6. PubMed ID: 21796066
[TBL] [Abstract][Full Text] [Related]
40. Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.
Gamsjaeger S; Hofstetter B; Zwettler E; Recker R; Gasser JA; Eriksen EF; Klaushofer K; Paschalis EP
Osteoporos Int; 2013 Jan; 24(1):339-47. PubMed ID: 23229465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
